Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Funding
Sign In Sign Up
Night Mode
JAK Inhibitor Drug Market Set to Reach USD 25.77 Billion by 2035
The global Janus Kinases (JAKs) inhibitor drug market is experiencing remarkable growth, driven by increasing prevalence of autoimmune diseases, advancements in drug development, and expanding therapeutic indications. JAK inhibitors represent a class of targeted therapies that modulate immune responses by blocking specific signaling pathways, offering effective treatment options for conditions...
0 Comments ·0 Shares ·82 Views ·0 Reviews
Please log in to like, share and comment!